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Lentiviruses control virion production via posttranscriptional regulation mediated by the viral Rev protein. In this study,
we demonstrate that the Rev regulation of SIVmac239 can be replaced by the presence of the cis-acting transport element
(CTE) of the type D simian retroviruses 1 (SRV-1). To avoid the possibility of generating revertants, the Rev-independent
SIV clones have both rev and the Rev responsive element (RRE) destroyed by multiple point mutations that do not affect
the overlapping tat and env open reading frames. Virus stocks generated from these Rev-independent SIV molecular clones
can infect and can be propagated in rhesus peripheral blood mononuclear cells (PBMCs). Therefore, the Rev/RRE system
of SIVmac239 can be replaced by the SRV-1 CTE as previously shown for HIV-1. In both rhesus and human primary cells,
the replicative capacity of the Rev-independent SIV is 10- to 20-fold lower than that of the wild-type virus. Rhesus PBMC-
derived virus stocks of the Rev-independent SIV have lower infectivity. Interestingly, in CEM 1 174 cells, no difference in
replicative capacity between wild-type and Rev-independent SIV has been observed. The Rev-independent SIV has a stable
genotype after several passages in primary cells. The availability of such Rev-independent viruses will allow the study of
the role of Rev in pathogenesis and the potential generation of attenuated SIV strains. q 1997 Academic Press
INTRODUCTION a putative cellular factor(s) (Tabernero et al., 1997) that
is present in a wide range of mammalian cell types. The
The complex retroviruses can be distinguished from CTEs of different members of the SRV/D family (SRV-1,
the simple retroviruses, since they regulate their expres- SRV-2, and MPMV) are highly homologous and were
sion via viral proteins using both transcriptional and post- shown to replace the Rev/RRE regulatory system to a
transcriptional mechanisms and since they produce sev- similar extent (Tabernero et al., 1996). We showed that
eral accessory proteins. Since Rev regulation is the most Rev-independent HIV-1 can infect and propagate in hu-
conserved regulatory mechanism in lentiviruses, we are man primary lymphocytes (PBMCs) and can be main-
interested in understanding the role of Rev in virus propa- tained in culture over long periods of time without rever-
gation and pathogenicity in vivo. Previously, it was shown sion to wild-type, loss of the SRV-1 CTE, or phenotypical
that the Rev/Rev responsive element (RRE) regulatory
changes of the lower replicative capacity (Zolotukhin et
system of HIV-1 can be replaced by the cis-acting trans-
al., 1994; Tabernero et al., 1996).
port element (CTE) from the simian type D retroviruses
Thus far, all efforts toward generating attenuated SIV(SRV/D), resulting in Rev-independent virus expression
clones were targeted to eliminate the accessory genes(Bray et al., 1994; Zolotukhin et al., 1994; Tabernero et
with the goal of changing the virus–host interactionsal., 1996). The CTE is necessary for SRV/D expression,
(Kestler et al., 1991; Daniel et al., 1992; Wyand et al.,since its removal abolishes the production of infectious
1996). To understand the contribution of Rev regulationvirus (Tabernero et al., 1996; Ernst et al., 1997b). The CTE
in the pathogenesis in a nef-deleted molecular clone offolds into an extended stem-loop structure consisting of
SIV, we focused on the replacement of posttranscrip-two internal loop regions separated by a stem structure
tional Rev regulation by alternative mechanisms such as(Tabernero et al., 1996; Ernst et al., 1997a). The internal
the CTE of the SRV-1. In this study, we demonstrate thatloop regions are thought to represent interaction sites of
these Rev-independent clones of SIVmac239 can infect
and replicate in rhesus PBMCs as well as in human cell
lines and primary lymphocytes. Therefore, the Rev/RRE
system of SIVmac can be replaced by the posttranscrip-1 The U.S. Government’s right to retain a nonexclusive royalty-free
license in and to the copyright covering this paper, for governmental tional regulatory element of SRV-1. These Rev-indepen-
purposes, is acknowledged. dent viruses grow with lower replicative capacity than
2 To whom correspondence should be addressed. ABL-Basic Re- the wild-type SIVmac239 in vitro, and interestingly, theysearch Program, NCI–FCRDC, Building 535, Room 110, P.O. Box B,
have a lower infectivity. Analysis of the Rev-independentFrederick, MD 21702-1201. Fax: (301) 846-7152. E-mail: felber@ncifcrf.
gov. virus after several passages in primary rhesus lympho-
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cytes revealed a stable genotype (no rev/ revertants, no molecular clone pMA239 (Shibata et al., 1991) with the
mutated fragments. pMA239 contains the intact molecu-CTE loss). The availability of such a Rev-independent
virus will allow us to study the role of Rev in pathogenesis lar clone from the HindIII site at nt -41 to the SacI site
at nt 11,433 cloned into pUC18. After introduction intoand to study the potential generation of attenuated SIV
strains. Escherichia coli strain HB101, the transformants were
grown at 307 in L-broth and were stable.
MATERIALS AND METHODS
Production of viral stocks and cell-free infections
Recombinant plasmids
Heparinized venous blood was obtained from healthy
All constructs were made using the p239SpE3* con-
pathogen-free rhesus macaques (New England Primate
taining the 3* portion of the infectious pathogenic molec-
Center) and from healthy sero-negative blood donors.
ular clone SIVmac239nef/ (Kestler et al., 1990; Regier et
PBMCs were isolated by Histopaque (Sigma) density
al., 1990; Kestler et al., 1991). Site-directed mutagenesis
centrifugation and were resuspended at a concentration
or PCR using long mutated oligos was employed to intro-
of 106 cells per milliliter in RPMI 1640 medium (Biofluids)
duce the nucleotide changes. Mutagenesis was de-
supplemented with 10% fetal bovine serum and stimu-
signed to introduce multiple nucleotide changes in rev
lated for 3 days with 5 mg/ml of phytohemagglutinine A
and RRE without affecting the overlapping tat and env
(PHA) (Sigma). Rhesus CD4/ lymphocytes were purified
reading frames. To allow these manipulations several
using Dynabeads M-450 CD4 (Dynal) and were grown at
restriction fragments were subcloned into bluescript vec-
a density of 2 1 106 cells/ml in complete RPMI 1640
tors. After sequence confirmation, the fragments were
medium. Human cell lines used in the experiments were
reinserted into p239SpE3*. All PCR products and mutants
293, CEM 1 174, and HUT78. For transfection experi-
were sequenced by the PCR-assisted fluorescent termi-
ments, all plasmid DNAs were purified by the Qiagen kit.
nator method (ReadyReaction DyeDeoxy Terminator Cy-
Ligation of the 5* portion of pVP-1 (a gift from P. Luciw)
cle Sequencing Kit; Applied Biosystems Inc.) and run
and of the derivatives of the p239SpE3* clones was per-
on the Applied Biosystems Model 373 DNA Sequencing
formed after digestion with SphI, followed by heat inacti-
System, and the data were analyzed by using
vation at 607 for 10 min and ligation with 7 ml of T4 DNA
Sequencher 3.0 (Gene Code Corp.). The rev ORF was
ligase (Epicentre Technologies Corp.) for 3 hr at room
destroyed by mutating the AUG initiator condon AUG to
temperature. The 400-ml ligation mixture contained 7 mg
AcG and by introducing four mutations in the second
of the SIV5* portion, 7 mg of the SIV3* portion, and 7 mg
coding exon, changing codon 75 Gln to stop, codon 77
of NheI-digested pFred25DNae (Stauber et al., submitted
Gln to stop, codon 78 Asn to Asp, and codon 79 Leu to
for publication), encoding the green fluorescent protein
Phe. Fifteen point mutations were introduced in RRE,
(GFP) as internal control. The ligation mixture was con-
changing the nucleotide composition of the putative Rev-
centrated by using Jetsorb. Twenty-one micrograms of
binding site and destroying the RRE structure. The follow-
the ligated DNAs were used to transfect overnight human
ing oligos were used for mutagenesis (lowercase letters
293 cells and seeded at a density of 106 cells per 60-
indicate changed nucleotides; /1 represents the first
mm plate the previous day, by the calcium phosphate
nucleotide of U3): oligo 13,692 (nt 8222 to 8274) 5*-GTT-
coprecipitation technique (Graham et al., 1977; Felber et
CTGCAATGGGaGCcGCcagcctGACcCTcACgGCaCAG-
al., 1990). The following day the cells were washed with
TCCCGAACTTTA-3*; oligo 13,693 (nt 8275 to nt 8310) 5*-
4 ml of DMEM. Transfection efficiency was monitored by
TTGGCTGGGATAGTcCAaCAgCAGCAACAGCTGTTG-
measuring GFP amounts in the fluorometer. Virus stocks
3*. To insert the CTE, the SacI–SacI fragment (nt 9226
were generated upon cocultivation with 107 rhesus
to 11433) was subcloned, generating a unique NcoI site
PBMCs. For cell-free infection, rhesus primary lympho-
(nt 9281) located downstream of the env terminator. The
cytes were washed twice with phosphate-buffered saline
173-nt SRV-1 CTE (termed CTE) (Tabernero et al., 1996)
(PBS; Gibco) and infected cell-free supernatants con-
was PCR-amplified using a sense primer providing NcoI
taining equal amounts of SIV p27gag (Cellular Products).
and SmaI and an antisense primer containing additional
After incubation for 4 hr at 377, the cells were washed
terminators of translation followed by BamHI, SpeI, and
with PBS and cultured in complete RPMI 1640. Five units
NcoI. The CTE was cloned into in NcoI site of the sub-
of recombinant human interleukin-2 (Gibco) per milliliter
cloned SacI fragment. This fragment was subcloned into
was also added to the cultures. The cell cultures were
wild-type as well as into the Rev/RRE-deficient plasmids,
fed and monitored twice a week for Gag production using
generating pSIV3*.CTE and pSIV3*R(0)Rev(0)CTE, re-
the SIV p27gag antigen capture assay.
spectively. The 240-nt CTE (termed CTE240) (Zolotukhin
et al., 1994) was amplified using primers providing SmaI Western immunoblot
and BamHI, respectively, and was used to replace the
173-nt CTE as a SmaI– BamHI fragment. Intact molecular A cell extract of 293 cells was prepared 2 days post-
transfection and analyzed on 12.5% denaturing polyacryl-clones were also generated for some of the constructs
by replacing an SphI– EcoRI fragment of the infectious amide gels (Hadzopoulou-Cladaras et al., 1989). To de-
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tect the Gag proteins, the blots were hybridized with a clones by replacing the SphI–EcoRI fragment of the in-
fectious molecular clone pMA239 with the mutated frag-rabbit anti-SIV Gag antiserum (p16B2120, a gift from R.
Benveniste). To detect Nef expression, the blots were ments of p239SpE3* containing the 3* portion of the virus.
We did not observe qualitative differences in the proper-analyzed with anti-Nef antiserum provided by the NIH
AIDS Research and Reference Reagent Program (Cata- ties of the viruses generated after DNA transfections us-
ing either in vitro ligated DNA fragments or the molecularlog No. 1884). The proteins were visualized after incuba-
tion of the blots with 125I-labeled protein A and autoradi- clones (data not shown), except that intact molecular
clones were more efficient.ography.
The molecular clones expressing the wild-type SIV and
the Rev/RRE-deficient clones that contain the 173-nt SRV-Determination of virus titer
1 CTE were transiently transfected into 293 cells, and
The 50% infectious dose (ID50) of PBMC-derived cul- Gag production was measured by the p27gag antigen cap-
tures was determined as described (McDougal et al., ture assay. These data revealed that the RRE/Rev-defi-
1985; Albert et al., 1990). Briefly, 75 ml of each virus cient clone containing the CTE expressed about 15-fold
dilution (two 10-fold dilutions followed by four 5-fold dilu- lower levels of Gag compared to wild-type SIV. The cell
tions) was added to 10 parallel wells of a 96-well plate. extracts were subjected to Western immunoblot analysis
To each well 1 1 105 CEM 1 174 cells were added in following incubation with a rabbit anti-SIV Gag antiserum
150 ml medium. The cells were incubated with the virus that preferentially detects the p16MA portion of Gag (Fig.
overnight and then washed at Day 1 and Day 2 postinfec- 1B). We detected both precursor PR55gag and the pro-
tion. The cultures were split 1:4 on Days 3, 7, and 11. On cessed p16MA from both samples. Figure 1B shows fur-
Day 14, a 200-ml sample was analyzed using the SIV ther that the efficiency of PR55gag processing of the Rev-
p27gag antigen capture assay. The ID50 was defined as independent SIV is severely affected, indicating impair-
the reciprocal of the virus dilution resulting in 50% posi- ment of infectivity of this virus produced by the 293 cells.
tive wells (Reed-Muench calculation). The negative con- The Rev-independent SIV cannot produce Nef protein,
trol consisted of five wells containing only cells. since the CTE was inserted into the nef gene. Since the
Nef AUG located in the overlapping env open reading
RESULTS frame is present in pSIV.R(0)Rev(0)CTE, a Nef peptide
could be produced spanning amino acids 1 to 70 of Nef,Generation of Rev-independent SIVmac239
followed by 14 amino acids and a terminator of transla-
tion encoded by the CTE region. Western immunoblotWe generated a molecular clone based on SIVmac239
(Regier et al., 1990), named pSIV.R(0)Rev(0), that has assay confirmed the presence of Nef produced from the
wild-type SIV, whereas no Nef protein could be detectedboth components of the rev/RRE system eliminated and
hence is inactive (Fig. 1A). Multiple point mutations were from the Rev-independent SIV that contains the CTE in
the nef open reading frame (data not shown).introduced to destroy both rev and RRE without affecting
the overlapping tat and env reading frames to ensure the
inability of this clone to revert to wild-type upon long- The Rev-independent SIV is infectious and can be
term cultivation. The rev open reading frame contains 1 propagated upon cocultivation in rhesus PBMCs
point mutation in the first coding exon (destroying the
AUG initiation codon) and 4 point mutations in the second Next, we tested whether the CTE-containing SIVs are
infectious and can be propagated upon cocultivation withcoding exon (introducing two stop codons and changing
Asn78Leu79 in the activation domain to Asp78Phe79). In rhesus PBMCs. Human 293 cells were transfected with
the ligated 5* and corresponding 3* portions of SIV-addition, 15 point mutations were introduced into the
RRE designed to destroy the putative Rev-binding site mac239 which were wild-type, R(0)Rev(0)Nef(/), or
R(0)Rev(0)Nef(0) containing the SRV-1 CTE. The nextand the secondary structure of RRE. This clone,
pSIV.R(0)Rev(0), has been used to insert an alternative day, the transfected cells were cocultivated with rhesus
PBMCs and virus production was monitored by measur-posttranscriptional control element such as the CTE of
SRV-1 (Zolotukhin et al., 1994). The CTE was inserted ing p27gag expression (Fig. 2A). These data show that
elimination of rev and RRE in pR(0)Rev(0) abolished vi-into the NcoI site located 3* to the terminator of env at nt
9281, generating the Rev-independent nef0 derivatives. rus production as expected. In contrast, the presence of
both the 240-nt CTE (CTE240) and the 173-nt CTE (CTE)Previously, we showed that the 173-nt SRV-1 CTE re-
places Rev function of HIV-1 equally well as the 240- resulted in the generation of virus able to infect and
propagate in rhesus primary PBMCs. We had previouslynt CTE and therefore this element contains all features
necessary for function (Tabernero et al., 1996). We made demonstrated that the 173-nt CTE contains all the fea-
tures necessary for function in the Rev-independent HIV-constructs containing either the 173- or the 240-nt ele-
ment to ensure optimal exposure of this element within 1 clones (Tabernero et al., 1996). Since there is no signifi-
cant difference observed in the propagation of the Rev-the nef region of SIV and to achieve efficient function. For
some of the constructs, we generated intact molecular independent SIVs carrying the 240-nt CTE or the 173-nt
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FIG. 1. Expression of the Rev-independent molecular clone of SIVmac239. (A) Recombinant molecular clones of SIVmac239. The rev ORF and
RRE were destroyed without affecting the overlapping tat and env ORF upon insertion of 4 and 15 point mutations, respectively. In R(0)Rev(0)CTE,
the CTE of SRV-1 was inserted into the nef gene, generating a nef derivative. An intact molecular clone that has the R(0)Rev(0)CTE genotype was
generated by replacing the SphI–EcoRI fragment of the infectious molecular clone pMA239. (B) Expression of wild-type and Rev-independent SIV.
Human 293 cells were transfected with pSIVmac239 and the 173-nt CTE-containing pSIVR(0)RRE(0).CTE. Cell extracts were analyzed on a Western
immunoblot after incubations with rabbit anti-SIV Gag antiserum and 125I-labeled protein A. The positions of PR55gag and the processed p16MA
proteins are shown. The positions of the 14C-labeled rainbow markers are indicated.
CTE, we concluded that both CTEs function efficiently phocytes to demonstrate cell-free infection by the Rev-
independent SIV (data not shown). Similar data were ob-within the context of the SIV mRNAs. In subsequent ex-
periments, we used the Rev-independent SIV containing tained in primary cells from different monkeys and by the
use of different virus stocks. In addition, primary culturesthe 173-nt CTE. Comparison to the replication of wild-
type SIV shows that the replicative capacity of the Rev- as shown in Figs. 2A and 2B revealed a steady level of
virus expression, demonstrating that the Rev-indepen-independent SIVs is about 10-fold lower upon reaching
plateau. Additional experiments using different pools of dent SIV can be propagated continuously in primary cells.
To understand whether the Rev replacement or the inser-rhesus PBMC cultures gave similar results. No virus pro-
duction could be detected from transfected 293 cells tion of the CTE in the 3* portion of the virus is responsible
for the lower replicative capacity of the virus, we insertedwithout cocultivation (data not shown). These data clearly
demonstrate that the measured Gag production is the the CTE at the same location into the wild-type SIV, which
maintains an intact Rev/RRE system generating pSIV.CTE.result of virus propagation in the PBMCs.
Upon infection of rhesus PBMCs (Fig. 2B), SIV.CTE repli-
cated with similar kinetics and to a similar extent as theCell-free infection of primary rhesus cells by the Rev-
wild-type SIV. These data demonstrate that the Rev replace-independent SIV results in continuous virus
ment is responsible for the distinct replication phenotypeproduction
of the Rev-independent SIV.
We next asked whether the Rev-independent SIV can
establish a productive infection in rhesus PBMCs after Infection of Rev-independent SIV into human cell lines
cell-free infection. The results of a representative experi- and primary PBMCs
ment are shown in Fig. 2B, demonstrating that the Rev-
independent SIV productively infected rhesus PBMCs. We tested whether the Rev-independent SIV can also
mediate cell-free infection into human cell lines and hu-As expected from the cocultivation experiment, the Rev-
independent SIV replicated to a lesser extent than the man primary PBMCs. Rhesus PBMC-derived virus stocks
were used to infect the human CEM1 174 cell line usingwild-type SIV. We also used CD4/-selected rhesus lym-
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FIG. 2. The Rev-independent SIV can be propagated in rhesus primary cells. (A) Virus propagation after cocultivation with rhesus PBMCs. Human 293
cells were transfected with the ligated 5* portion (pVP-1) and p239SpE3*-based 3* portions of the molecular clones that are wild-type, R(0)Rev(0)Nef(0),
or R(0)Rev(0)Nef(0) containing the CTE. We generated clones that contain the 173-nt (CTE) and the 240-nt (CTE240) elements, respectively. The transfected
cells were cocultivated with rhesus PBMCs. Virus production was quantitated by using a SIV p27gag antigen capture assay (Cellular Products). Fresh rhesus
PBMC were added at Day 15. Infectivity titers were determined from the wild-type SIV and Rev-independent SIV at Days 11 and 18 postinfection, respectively.
(B) Cell-free infection and propagation of Rev-independent SIV in rhesus PBMCs. Filtered supernatants from infected primary lymphocyte cultures (ranging
from 50,000 to 64,000 pg p27gag/ml) were used to infect 107 PHA-stimulated rhesus PBMCs. Fresh rhesus PBMCs were added once at Day 15. Virus
production was monitored by measuring Gag expression in the supernatants at the indicated days postinfection. The infections were performed using
wild-type SIV, the CTE-containing wild-type virus, the Rev-independent SIV, and the supernatant of the Rev/RRE-deficient clone R(0)Rev(0), respectively.
equal amounts of input virus (measured as p27gag). The finding is not unique to the Rev-independent SIV. We
observed that the Rev-independent HIV replicated withresults of a representative experiment are shown in Fig.
3A. Virus production was monitored by measuring p27gag similar kinetics in Jurkat cells, whereas in human PBMCs,
it propagated about 10-fold less than wild-type HIV (Ta-expression at the indicated time points. Interestingly, in
CEM 1 174 cells, the Rev-independent SIV replicates bernero et al., 1997). These data suggest that the cell
type-specific factors may affect CTE function.with an efficiency equal to that of wild-type SIV. This
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FIG. 3. Cell-free infection and virus propagation in human cells. (A) Virus stocks were generated after 2 days of cocultivation of transfected 293
cells with rhesus PBMCs. Equal amounts of virus (determined by p27gag capture antigen assay) were used to infect 5 1 106 CEM 1 174 cells and
virus propagation was monitored over time by measuring p27gag. The cell cultures were monitored and split twice a week. The culture of the wild-
type SIV was discontinued at Day 16, since the infected cells died. (B and C) Virus stocks (30,000 pg p27gag/ml each) produced from the infected
CEM 1 174 cells shown in A were used to infect 5 1 106 HUT78 cells (B) and 1.5 1 107 human PBMCs (C). Human PBMCs were prepared as
described previously (Zolotukhin et al., 1994). Cells were infected and monitored as described above. The PBMC cultures were not split. The culture
of the wild-type SIV was discontinued at Day 25, since the infected cells died.
Virus stocks generated from the CEM 1 174 cul- the Rev-independent SIV can infect several cells of
human origin. Interestingly, while the replacement oftures were then used to infect the HUT78 cell line
(Fig. 3B) and human PBMCs (Fig. 3C). The Rev-inde- Rev regulation did not affect virus propagation in CEM
1 174 cells, a much lower replicative capacity of thependent SIV had a 5-fold lower replicative capacity
than wild-type SIV in HUT78 cells upon reaching pla- Rev-independent SIV was observed in primary cells
of both rhesus and human origin. These data indicateteau. However, in human PBMCs, Rev-independent
SIV propagates about 20-fold less efficiently com- that the cellular environment may contribute to CTE
function in SIV.pared to wild-type SIV. These data demonstrate that
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FIG. 3—Continued
Infectivity of the Rev-independent virus is reduced pared to wild-type SIV in rhesus PBMCs. These findings
may be the result of the less efficient CTE-mediated virus
To further characterize the Rev-independent SIV, we
expression.
determined the infectivity of the wild-type SIV and Rev-
independent virus collected at Days 11 and 18, respec-
Continuous propagation of a Rev-independent SIV in
tively, in the experiment shown in Fig. 2A. Serial dilutions
rhesus PBMCs without loss of rev-genotype
of the viruses were used to infect CEM 1 174 cells.
Virus production was measured using the p27gag antigen To determine whether the genotype of the Rev-inde-
capture assay at 2 weeks postinfection. The titer of the pendent SIV is stable after repeated infection cycles, the
wild-type SIV stock was 1 ID50/pg of p27
gag, whereas the Rev-independent SIV (Fig. 2A, collected at Day 15) was
titer of the Rev-independent stock was 1 ID50 per 10 pg subsequently passaged three more times through puri-
of p27gag. Therefore, the infectivity of the Rev-indepen- fied primary rhesus CD4/ lymphocytes. Virus stocks
dent SIV stock is about 10-fold lower than that of the were collected at about 10–20 days postinfection when
wild-type SIV. virus production reached maximum. The regions span-
One reason for the lower infectivity of the Rev-indepen- ning the first and second exons of rev as well as the
dent SIV could be the production of immature particles, CTE were PCR-amplified and cloned, and 15 indepen-
since we have found that this virus showed less efficient dent clones from each region were sequenced. All clones
processing of Gag precursor protein in 293 cells (Fig. contained the introduced mutations and therefore no re-
1B). Using Western immunoblot analysis, we analyzed version of the rev0 genotype was detected. In addition,
cell extracts from rhesus PBMCs and CEM 1 174 cells we did not observe any loss of the CTE. These data
infected by wild-type and Rev-independent SIV (data not confirm that the genotype of the Rev-independent SIV
shown). We did not observe any difference in the pro- is stable upon in vitro propagation. This finding is in
cessing efficiency of the Gag polyprotein. We further ana- agreement with our previous results with long-term prop-
lyzed virions from PBMC cultures by electron microscopy agated Rev-independent HIV-1 molecular clones (Zolo-
which revealed no difference in the proportion of imma- tukhin et al., 1994; Tabernero et al., 1996).
ture and mature particles produced by these viruses.
Therefore, less efficient Gag processing was observed DISCUSSION
only in the transfected 293 cells.
Taken together, the Rev-independent SIV has a lower In this study, SIVmac239 variants that have the Rev/
RRE regulatory system replaced by the CTE posttran-replicative capacity (Fig. 2) and lower infectivity com-
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scriptional control element of SRV-1 were generated. intact SIV (SIV.CTE) did not affect the growth properties
of the virus. By comparing Rev-independent molecularThese Rev-independent viruses can be propagated in
rhesus PBMCs and cells of human origin. The experi- HIV clones that differ only in the presence/absence of
nef, we have also shown that the in vitro growth proper-ments presented here demonstrate another example of
a successful replacement of a posttranscriptional regula- ties of Rev-independent HIV-1 are not dependent on the
presence of a functional nef gene (A. Valentin et al., sub-tory system by the use of the type D retroviral CTE. These
CTEs have been shown to replace HIV-1 Rev regulation mitted for publication) but are due only to the substitution
of the Rev regulation. From our previous work, studyinggenerating Rev-independent HIVs that propagate with
about 5- to 10-fold lower replicative capacity than that of subgenomic gag expression vectors (Tabernero et al.,
1996), it became clear that CTE-mediated expression iswild-type virus in human primary lymphocytes (Zolotukhin
et al., 1994). Furthermore, we have shown that the pres- less efficient than Rev/RRE regulation. The lower replica-
tive capacity and the lower infectivity of the Rev-indepen-ence of the SRV-1 CTE can alleviate the posttranscrip-
tional restriction of the HPV-16 L1 mRNA, resulting in L1 dent SIV are most likely the result of the change in the
posttranscriptional regulatory system. Therefore, theprotein production in cells other than the differentiated
keratinocytes (Tan et al., 1995). Taken together, the CTE change in the posttranscriptional regulatory system has
a profound effect on virus replication in vitro which hasrepresents a powerful control system that can be applied
to overcome different posttranscriptional restrictions. It not been observed for the deletion of nef and vpr (Gibbs
et al., 1994).remains to be seen whether CTE-mediated posttran-
scriptional expression will permit establishment of infec- Since the replacement of the Rev/RRE with the alterna-
tive posttranscriptional regulatory system CTE resultedtion in an animal model.
The Rev-independent virus can infect rhesus primary in the generation of SIV variants that grow with reduced
replicative capacity in primary cells in vitro, this raiseslymphocytes in vitro and has a stable genotype (no rev/
revertants, no CTE loss) after several passages. After the possibility that these viruses have also attenuated
growth properties in vivo, which may result in a reducedcompletion of this work, Rizvi et al. (1996) published SIV-
mac239-based vectors that utilize MPMV CTE instead of pathogenic potential. In addition, the Rev-independent
SIV lacks nef and could be less pathogenic than SIV-Rev/RRE for expression of gag/pol and a truncated env
protein. The use of these subgenomic vectors pseu- mac239D3. Therefore, the Rev-independent SIV may
have an altered or diminished capacity to cause chronicdotyped with MLV Env allowed a single-round infection
in HeLaT4 cells. This is in contrast to the work presented active infections because the elimination of viral Rev reg-
ulation may result in an altered association with the host.here, since we demonstrated productive infections and
continuous propagation of Rev-independent molecular The availability of such a Rev-independent SIV will allow
the study of the role of viral Rev regulation in pathogene-clones of SIV in rhesus PBMCs.
There is great interest in the development of attenu- sis in a primate animal model and will contribute to our
knowledge about lentiviral expression strategy in vivo.ated SIV clones since it has been demonstrated that
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